EZZ Life Science Holdings Ltd (EZZ) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.198x

Based on the latest financial reports, EZZ Life Science Holdings Ltd (EZZ) has a cash flow conversion efficiency ratio of -0.198x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.50 Million ≈ $-3.89 Million USD) by net assets (AU$27.81 Million ≈ $19.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of EZZ Life Science Holdings Ltd to measure how much of total assets are equity-financed.

EZZ Life Science Holdings Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how EZZ Life Science Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of EZZ Life Science Holdings Ltd to evaluate the quality of earnings relative to operating cash generation.

EZZ Life Science Holdings Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EZZ Life Science Holdings Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kritika Wires Limited NSE:KRITIKA	0.011x
Leeuwin Metals Ltd AU:LM1	-0.042x
Safeture AB ST:SFTR	0.096x
Southern Hemisphere Mining Ltd AU:SUH	-1.457x
Pointerra Ltd AU:3DP	2.015x
Volution Group plc LSE:FAN	0.147x
Curis Inc NASDAQ:CRIS	-0.708x
Smartiks Yazilim AS IS:SMART	0.098x

Annual Cash Flow Conversion Efficiency for EZZ Life Science Holdings Ltd (2018–2024)

The table below shows the annual cash flow conversion efficiency of EZZ Life Science Holdings Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see EZZ company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$28.09 Million ≈ $19.87 Million	AU$4.35 Million ≈ $3.08 Million	0.155x	-46.20%
2023-12-31	AU$21.32 Million ≈ $15.09 Million	AU$6.14 Million ≈ $4.35 Million	0.288x	+4.67%
2022-12-31	AU$14.58 Million ≈ $10.32 Million	AU$4.01 Million ≈ $2.84 Million	0.275x	+64.84%
2021-12-31	AU$11.39 Million ≈ $8.06 Million	AU$1.90 Million ≈ $1.35 Million	0.167x	+565.80%
2020-12-31	AU$10.11 Million ≈ $7.15 Million	AU$253.53K ≈ $179.39K	0.025x	-93.38%
2019-12-31	AU$7.85 Million ≈ $5.56 Million	AU$2.97 Million ≈ $2.10 Million	0.379x	-25.04%
2018-12-31	AU$823.91K ≈ $582.97K	AU$416.33K ≈ $294.58K	0.505x	--

About EZZ Life Science Holdings Ltd

AU:EZZ Australia Biotechnology

Market Cap

$16.64 Million

AU$23.52 Million AUD

Market Cap Rank

#25686 Global

#1122 in Australia

Share Price

AU$0.50

Change (1 day)

+7.53%

52-Week Range

AU$0.37 - AU$3.32

All Time High

AU$4.93